AKT1 and cancer: An alternative mechanism for the therapeutic properties of SeNPs is autophagic death of cancer cells, which can be triggered by enhancing signaling pathways associated with beclin-1 [32], suppressing the p62 protein [33,34,35] and by inhibiting the PI3K/AKT/mTOR pathway.